Young adults with cystic fibrosis (CF) are particularly vulnerable to depression. As a consequence, these patients may have low rates…
Patricia Inácio, PhD
Patricia holds her PhD in cell biology from the University Nova de Lisboa, Portugal, and has served as an author on several research projects and fellowships, as well as major grant applications for European agencies. She also served as a PhD student research assistant in the Department of Microbiology & Immunology, Columbia University, New York, for which she was awarded a Luso-American Development Foundation (FLAD) fellowship.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Patricia Inácio, PhD
Platelets circulating in the blood of cystic fibrosis (CF) patients do not contribute to the increased levels of pro-inflammatory cytokines known to exist…
Long-term Tiotropium Bromide Therapy in CF Patients Linked to Improvements in Lung Function Decline
Adult patients with cystic fibrosis (CF) show improvements in lung function decline when treated with a high dosage of tiotropium…
A recent study confirmed that different structure and composition of airway microbiota (symbiotic helpful and harmful microrganisms) exist in cystic…
Individuals carrying the mutated gene for cystic fibrosis (CF) show an increased risk for asthma, in particular CF carriers from Asian countries.
Elevated Acidity in Liquid Coating the Airways of CF Patients Linked to Viscous Mucus Production
New research from the University of Iowa’s Pappajohn Biomedical Institute (PBI) suggested that the sticky mucus found in cystic fibrosis (CF) patients is more viscous…
Ivacaftor (Kalydeco) treatment improves airway flexibility and capacity in patients with cystic fibrosis (CF), according to the results of a study,…
Arch Biopartners is collaborating with the University of Cincinnati (UC) for a new drug candidate, AB569, for treating Pseudomonas…
Young children with cystic fibrosis (CF) exhibit a more pro-inflammatory gastrointestinal microbiome, which may underlie impaired nutrient absorption, according to…
A recent study describes a new assay, CFseq, that uses dried blood spots to screen for defects in the gene underlying…